Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Instadip 50

Approved

STANDARD

Instadip 50

Sun Pharmaceutical Industries Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 74fb88b6cbda8bac
Company: Sun Pharmaceutical Industries Limited
Type: Standard

Approval Details

Approval Id: 74fb88b6cbda8bac
Drug Approval Philippines Name: Instadip 50
Product Name: Instadip 50
Registration Number: DRP-12978
Brand Name: Instadip 50
Generic Name: Sitagliptin (as phosphate)
Dosage Form: Film-Coated Tablet
Dosage Strength: 50 mg
Manufacturer: Sun Pharmaceutical Industries Limited
Importer: Sun Pharma Philippines, Inc.
Distributor: Sun Pharma Philippines, Inc.
Company Detail Path: /organization/sun-pharmaceutical-industries-limited
Issuance Date: 24 May 2024
Expiry Date: 11 November 2027
Pharmacologic Category: Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

74fb88b6cbda8bac

Type

Standard

Back to Philippines FDA Approvals

Instadip 50 - Philippines FDA Drug Approval Details